Overall Survival After Neoadjuvant Versus Adjuvant Chemotherapy for Invasive Urothelial Carcinoma of the Bladder: A Real-world Multicenter Cohort Study
Background/Aim: Invasive urothelial carcinoma of the urinary bladder carries a high risk of micrometastatic spread, and perioperative chemotherapy is a key component of curative-intent treatment. Neoadjuvant chemotherapy (NAC) has the strongest supporting evidence, whereas the role of adjuvant chemotherapy (AC) remains...